Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 173   

Articles published

GSK 1,414.00 +16.00 (1.14%)
price chart
Recovering GlaxoSmithKline plc Won't Be Cheap For Much Longer
Pharmaceutical giant GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is one of those rock-solid stocks that you despair of being able to pick up at a bargain price.
GLAXOSMITHKLINE (NYSE:GSK) Ebola vaccine to be ready by end of year  WallStreet Scope
GlaxoSmithKline net earnings dips by 62% in Q3
Related articles »  
Why GlaxoSmithKline plc And Shire PLC Could Be The Perfect Pharmaceutical ...
So, with a potent mix of income, growth and value, GlaxoSmithKline and Shire could prove to be the perfect pharmaceutical partnership.
GlaxoSmithKline plc Is Becoming More Attractive By The Day
GlaxoSmithKline plc's (LSE: GSK) share price is falling again today, which is great news, as at these prices the company is a steal.
Related articles »  
GlaxoSmithKline plc Jumps After Beating City Expectations
Glaxo remains under investigation by regulators within in both the UK and US. But still, the conclusion of this investigation has removed much uncertainty surrounding the group's future, uncertainty which has dragged on Glaxo's share price. The company ...
GlaxoSmithKline plc Shares Up After Earnings  ValueWalk
GlaxoSmithKline Unveils Cost-Saving Plan, Considers IPO of HIV Business  Wall Street Journal
Related articles »  
2 Numbers That Could Make GlaxoSmithKline plc A Spectacular Buy
The business has seen sales in China collapse. And concern about the long-term effect that the corruption case will have on future revenue growth has weighed heavily on GlaxoSmithKline for many months now. So news last month that the case had been ...
Related articles »  
Should I Invest In GlaxoSmithKline Plc Now?
GlaxoSmithKline When I last wrote about pharmaceutical giant GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) back in August, the shares were at 1382p.
5 Things GlaxoSmithKline plc Stock's Management Wants You to Know
British pharma giant GlaxoSmithKline (NYSE: GSK ) is at the epicenter of the industrywide crisis known as the patent cliff.
Related articles »  
Beat The FTSE 100 With SABMiller plc, GlaxoSmithKline plc And British ...
With the FTSE 100 having fallen by over 8% during the last month, beating the returns on the index has become a priority for a number of UK investors.
Related articles »  
This May Be Your Last Chance To Buy Diageo plc, GlaxoSmithKline plc And ...
As well as Glaxo, I'm considering investing in several of the five FTSE shares highlighted within this exclusive wealth report.
Related articles »  
What Management Would Prefer You Didn't Know About GlaxoSmithKline plc
The actions of companies like GlaxoSmithKline can take investors by surprise -- especially when they are otherwise solid companies producing robust earnings and dividends.